Screening for Colorectal Cancer

Ann Intern Med. 2024 Apr 9. doi: 10.7326/AITC202404160. Online ahead of print.ABSTRACTColorectal cancer (CRC) is the second leading cause of cancer death. Screening has been proven to reduce both cancer incidence and cancer-related mortality. Various screening tests are available, each with their own advantages and disadvantages and varying levels of evidence to support their use. Clinicians should offer CRC screening to average-risk persons aged 50 to 75 years; starting screening at age 45 years remains controversial. Screening may be beneficial in select persons aged 76 to 85 years, based on their overall health and screening history. Offering a choice of screening tests or sequentially offering an alternate test for those who do not complete screening can significantly increase participation.PMID:38588547 | DOI:10.7326/AITC202404160
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Source Type: research